India To Spend $510 Million Doubling Drug Inspectors, Adding State Staff
This article was originally published in PharmAsia News
India plans to spend $510 million over the next three years to double its staff of drug inspectors and install testing laboratories at ports in an effort to ensure the nation is making quality products.
You may also be interested in...
From efficacy endpoints to patient warehousing, US FDA advisors weigh in on vaccine development and regulatory review.
Several years ago, heart device giant Edwards Lifesciences realized it needed a new CAPA framework that shifts corrective and preventive action from a one-size-fits-all method to a more nuanced approach. See what Dan Buehner, director of quality engineering at Edwards Lifesciences, said about it here.
FDA's recommendation that COVID-19 vaccine sponsors conduct two months of median follow-up to support an emergency use authorization may not be long enough, some experts say in what can be viewed as validation for agency's position in battle with White House.